GlassScriptPhysician profile
E Ray Dorsey
NPI 1194759993
$144,689.36
in general payments reported to CMS, 2019-2025
17 companies · $3,965 in 2025
The $3,965 reported for 2025 was more than what 82% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $39K · 2021: $30K · 2022: $10K · 2023: $6,424 · 2024: $25K · 2025: $3,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Travel and Lodging: $2,125 · Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,235.00 |
| Travel and Lodging | $2,125.08 |
| Food and Beverage | $310.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi US Services INC. | $29,628.18 | 2019-2025 | |
| Genentech, INC. | $15,880.00 | 2020-2024 | |
| Tanabe Pharma America, INC. | $15,035.14 | 2023-2024 | |
| Abbvie INC. | $12,091.48 | 2019-2022 | |
| Biogen, INC. | $10,455.00 | 2020-2021 | |
| Eli Lilly and Company | $9,750.00 | 2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $8,532.00 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $8,067.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $7,399.76 | 2019-2021 | |
| Spark Therapeutics, INC. | $6,600.92 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $6,340.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $6,277.50 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,620.00 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $2,592.00 | 2020 | |
| Genentech USA, INC. | $2,070.00 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $1,350.00 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw E Dorsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.